Citation Impact

Citing Papers

Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data
1997 Standout
Pharmacology and Management of the Vitamin K Antagonists
2008 Standout
Long-Term Trends in the Incidence of and Survival with Heart Failure
2002 Standout
Next generation topoisomerase I inhibitors: Rationale and biomarker strategies
2007
Trends in case-fatality in 117718 patients admitted with acute myocardial infarction in Scotland
2000
Effect of Atenolol on Mortality and Cardiovascular Morbidity after Noncardiac Surgery
1996 Standout
Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis
2006 Standout
Oral Anticoagulant Therapy
2012 Standout
Emergency Hospitalizations for Adverse Drug Events in Older Americans
2011 Standout
A Comparison of Balloon-Expandable-Stent Implantation with Balloon Angioplasty in Patients with Coronary Artery Disease
1994 Standout
Health inequalities among British civil servants: the Whitehall II study
1991 Standout
Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction
1998 Standout
Effect of 3.2%vs3.8% Sodium Citrate Concentration on Routine Coagulation Testing
1997
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
2009 Standout
Regional Variation in Out-of-Hospital Cardiac Arrest Incidence and Outcome
2008 Standout
Impact of hospital thrombolysis policy on out-of-hospital response to suspected myocardial infarction
1993
Fish Intake, Contaminants, and Human Health
2006 Standout
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
Oral Anticoagulants
1998
Regulatory Functions of the Vascular Endothelium
1990 StandoutNobel
Explaining the Decrease in U.S. Deaths from Coronary Disease, 1980–2000
2007 Standout
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial
2002 Standout
Management of acute myocardial infarction in patients presenting with ST-segment elevation
2003
Oral Anticoagulants: Mechanism of Action, Clinical Effectiveness, and Optimal Therapeutic Range
2001 Standout
The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels
1996 Standout
Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty
2008 Standout
Survival after cardiac arrest outside hospital over a 12-year period in Gothenburg
1994
A Definition of Advanced Types of Atherosclerotic Lesions and a Histological Classification of Atherosclerosis
1995 Standout
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
The Pharmacology and Management of the Vitamin K Antagonists
2004 Standout
The TIMI Risk Score for Unstable Angina/Non–ST Elevation MI
2000 Standout
Quantifying heterogeneity in a meta‐analysis
2002 Standout
Bias in meta-analysis detected by a simple, graphical test
1997 Standout
Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration
1994 Standout
Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial
2006 Standout
Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients
1994 Standout
Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials
2003 Standout
The broad spectrum of unstable angina pectoris and its implications for future controlled trials
1986
Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents.
1994 Standout
Combination Antiretroviral Therapy and the Risk of Myocardial Infarction
2003 Standout
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis
2009 Standout
Coronary anatomy and arteriography in patients with unstable angina pectoris
1978
DNA Topoisomerase I Inhibitors: Chemistry, Biology, and Interfacial Inhibition
2009 Standout
Evaluating the federal role in financing health-related research
1996 StandoutNobel
American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy
2003
Prevalence of Total Coronary Occlusion during the Early Hours of Transmural Myocardial Infarction
1980 Standout
ACAT2 Is Localized to Hepatocytes and Is the Major Cholesterol-Esterifying Enzyme in Human Liver
2004 StandoutNobel
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
American Heart Association/American College of Cardiology Foundation guide to warfarin therapy11The American Heart Association makes every effort to avoid any actual or potential conflicts of interest that may arise as a result of an outside relationship or a personal, professional, or business interest of a member of the writing panel. Specifically, all members of the writing group are required to complete and submit a Disclosure Questionnaire showing all such relationships that might be perceived as real or potential conflicts of interest.This statement has been co-published in the April 1, 2003, issue of Circulation.This statement was approved by the American Heart Association Science Advisory and Coordinating Committee in October 2002 and by the American College of Cardiology Board of Trustees in February 2003. A single reprint is available by calling 800-242-8721 (US only) or writing the American Heart Association, Public Information, 7272 Greenville Ave, Dallas, TX 75231-4596. Ask for reprint No. 71-0254. To purchase additional reprints: up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies, call 410-528-4426, fax 410-528-4264, or e-mail klbradle@lww.com. To make photocopies for personal or educational use, call the Copyright Clearance Center, 978-750-8400.
2003
Angiographie morphology and the pathogenesis of unstable angina pectoris
1985
Variability of electrocardiographic and enzyme evolution of myocardial infarction in man.
1981
Blood pressure, stroke, and coronary heart disease
1990 Standout
Multicenter Evaluation of Lyophilized and Deep-frozen Plasmas for Assignment of the International Normalized Ratio
1999 StandoutNobel
Estrogen and Coronary Heart Disease in Women
1991 Standout
Protective Effects of Aspirin against Acute Myocardial Infarction and Death in Men with Unstable Angina
1983
Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data
2000 Standout
Beta blockade during and after myocardial infarction: An overview of the randomized trials
1985 Standout
Coronary Plaque Disruption
1995 Standout
Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients
2000 Standout
CORONARY HEART-ATTACKS IN EAST LONDON
1975
Influence of Three Types of Automated Coagulometers on the International Sensitivity Index (ISI) of Rabbit, Human, and Recombinant Human Tissue Factor Preparations
1999 StandoutNobel
College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: laboratory monitoring of oral anticoagulant therapy.
1998
Treatment with Histamine H2Antagonists in Acute Upper Gastrointestinal Hemorrhage
1985 Standout
Conducting Meta-Analyses inRwith themetaforPackage
2010 Standout
Vitamin E Supplementation and Cardiovascular Events in High-Risk Patients
2000 Standout
MYOCARDIAL ISCHÆMIA, RISK FACTORS AND DEATH FROM CORONARY HEART-DISEASE
1977
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
2002 Standout
Uses of coronary heart attack registers.
1978
RISK FACTORS FOR ISCHqMIC HEART-DISEASE IN NORMAL MEN AGED 40 Edinburgh?Stockholm Study
1978
Ischaemic Heart Disease in Young Women
1974

Works of B.M. Duncan being referenced

Prognosis of new and worsening angina pectoris.
1976
Effect of Concentration of Trisodium Citrate Anticoagulant on Calculation of the International Normalised Ratio and the International Sensitivity Index of Thromboplastin
1994
Natural history of acute coronary heart attacks. A community study.
1972
Pharmacokinetics (PK) of edotecarin (J-107088), a topoisomerase I inhibitor, in patients with metastatic breast cancer (mBC) or glioblastoma multiforme (GBM)
2005
Rankless by CCL
2026